Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 58 of OnKure Therapeutics, Inc.'s SEC filings and found 1 warrant series, 2 convertibles, 1 ATM program, 3 shelf registrations, 1 S-1 registration and 1 completed offering on file for OKUR. The latest dilution event on file is ATM sales on Aug 4, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ENGNenGene Holdings Inc.
UNCYUnicycive Therapeutics, Inc.
VXRTVaxart, Inc.
VANIVivani Medical, Inc.
NRXPNRx Pharmaceuticals, Inc.
IMUXImmunic, Inc.
VTVTvTv Therapeutics Inc.
BDTXBlack Diamond Therapeutics, Inc.
PMVPPMV Pharmaceuticals, Inc.
MISTMilestone Pharmaceuticals Inc.
ANIXAnixa Biosciences, Inc.
CBUSCibus, Inc.
NTHINeonc Technologies Holdings, Inc.
KZIAKazia Therapeutics Limited American Depositary Shares
TNXPTonix Pharmaceuticals Holding Corp.